Literature DB >> 361069

Group B beta haemolytic streptococci in the female genital tract: a study of four clinic populations.

J A Embil, T R Martin, N H Hansen, S W MacDonald.   

Abstract

The carrier rate of group B beta-haemolytic streptococci (GBS) was assessed in pregnant and non-pregnant women attending four clinics. Multiple sites were sampled and standard methods were used to isolate GBS. Colonization rates were highest in patients attending a venereal disease clinic but were not associated with other sexually transmitted diseases. Higher colonization rates were detected when multiple sites were sampled. Serotypes II and III occurred most frequently.

Entities:  

Mesh:

Year:  1978        PMID: 361069     DOI: 10.1111/j.1471-0528.1978.tb15603.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  6 in total

1.  Patterns of carriage of group B streptococci in genitourinary medicine clinic patients.

Authors:  E F Monteiro; K M Oxley; G Colman; J G Hastings
Journal:  Genitourin Med       Date:  1988-12

2.  What is the risk of beta-haemolytic streptococcal infection in obstetrics?: discussion paper.

Authors:  C S Easmon
Journal:  J R Soc Med       Date:  1984-04       Impact factor: 5.344

3.  Carriage of Streptococcus agalactiae in women and neonates and distribution of serological types: a study in Brazil.

Authors:  L C Benchetrit; S E Fracalanzza; H Peregrino; A A Camelo; L A Sanches
Journal:  J Clin Microbiol       Date:  1982-05       Impact factor: 5.948

Review 4.  Vaginitis: current microbiologic and clinical concepts.

Authors:  L V Hill; J A Embil
Journal:  CMAJ       Date:  1986-02-15       Impact factor: 8.262

5.  Carriage and transmission of group B streptococci among STD clinic patients.

Authors:  D H Jackson; S M Hinder; J Stringer; C S Easmon
Journal:  Br J Vener Dis       Date:  1982-10

6.  Group B streptococcus carriage and vulvovaginal symptoms: causal or casual? A case-control study in a GUM clinic population.

Authors:  C Shaw; M Mason; A Scoular
Journal:  Sex Transm Infect       Date:  2003-06       Impact factor: 3.519

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.